GlassScriptPhysician profile
James Richard Wilson
NPI 1598752669
$3,086.22
in general payments reported to CMS, 2019-2025
38 companies · $247 in 2025
The $247 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $201 · 2021: $255 · 2022: $410 · 2023: $810 · 2024: $627 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,595 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,594.68 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $440.57 | 2019-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Exeltis, USA INC. | $339.48 | 2020-2025 | Slynd |
| Astellas Pharma US INC | $248.07 | 2019-2024 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $163.96 | 2023-2025 | Myfembree, Gemtesa |
| Gynesonics, INC. | $128.01 | 2021 | |
| Myovant Sciences INC. | $122.24 | 2021-2022 | |
| Hologic Sales and Service, LLC | $120.99 | 2019-2025 | Myosure Tissue Removal Device, Novasure, Fluent Fluid Management System |
| Avion Pharmaceuticals | $116.30 | 2019-2023 | Balcoltra |
| Mayne Pharma Commercial LLC | $113.88 | 2023-2025 | |
| Channel Medsystems, INC. | $101.49 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.84 | 2022-2025 | |
| Allergan, INC. | $94.10 | 2019-2020 | |
| Sage Therapeutics, LLC | $86.23 | 2022-2024 | |
| Axonics, INC. | $76.30 | 2023-2024 | Axonics, Bulkamid |
| Exact Sciences Corporation | $76.04 | 2023-2025 | Cologuard Collection Kit |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $72.02 | 2019-2020 | |
| Aspira Women'S Health INC | $71.70 | 2023 | Ova1 |
| Agile Therapeutics, INC. | $69.65 | 2021-2024 | Twirla |
| Therapeuticsmd, INC. | $61.10 | 2019-2022 | |
| Becton, Dickinson and Company | $56.21 | 2019-2023 | Arista Ah Flexitip |
| Corcept Therapeutics | $35.91 | 2024 | Korlym |
| Organon LLC | $34.33 | 2023-2024 | |
| Novo Nordisk INC | $33.88 | 2021-2025 | Wegovy |
| Mylan Pharmaceuticals INC. | $32.35 | 2022 | |
| Daiichi Sankyo INC. | $31.93 | 2022-2023 | Injectafer |
| Virtus Pharmaceuticals LLC | $31.58 | 2021-2022 | |
| Coopersurgical, INC. | $26.80 | 2022 | |
| Convatec INC. | $26.75 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $25.22 | 2019-2024 | Gardasil, Gardasil 9 |
| Roche Diagnostics Corporation | $25.21 | 2019 | |
| Lupin INC. | $22.31 | 2020 | |
| Minerva Surgical, INC | $19.56 | 2024 | |
| Olympus America INC. | $17.57 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $16.25 | 2024 | |
| Mylan Specialty L.P. | $14.56 | 2023 | Yupelri |
| Abbott Laboratories | $12.74 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $12.58 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.